Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months
Aesthetic Surgery Journal · 2023
DOI: 10.1093/asj/sjac291 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Aesthetic Surgery Journal, 2023. Verfasst von W Grant Stevens und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cosmetic Techniques, Cellulite. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Revelle Aesthetics, Inc.
Abstract (Originalsprache)
Background
Safety and efficacy endpoints for the single-arm, multicenter, open-label pivotal study, CONtrolled Focal Fibrous Band Release Method (CONFFIRM) [NCT04743635] assessing targeted verifiable subcision (TVS) for the treatment of cellulite were met at 3 months postprocedure and have been published. Final, 12-month data describing durability of treatment effect and safety are presented here for the first time.
Objectives
The authors sought to evaluate safety and efficacy out to 12 months of initial treatment for a single TVS procedure performed employing the Avéli device (Revelle Aesthetics, Inc.; Mountain View, CA) to treat cellulite on the buttock and thigh areas of adult females.
Methods
Effectiveness was determined by 3 independent physicians employing the Cellulite Severity Scale and Global Aesthetic Improvement Scale to assess improvement of baseline photographs when compared with 3-, 6- and 12-month posttreatment photographs. Blinded participant-reported outcomes and safety evaluations were also performed at all postprocedure time points.
Results
Clinically significant improvement in primary endpoint Cellulite Severity Scale scores were sustained out to 1 year, improving by 1.50 (P < .0001) at 3 months, 1.54 points at 6 months, and 1.48 points at 12 months. Adverse events were mild and mostly resolved by the 12-month visit.
Conclusions
A single TVS treatment has durable efficacy and safety in reducing cellulite on the buttocks and thighs of women with moderate to severe cellulite out to 12 months posttreatment. Level of Evidence: 2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
ORCID-Profile: Jeremy B Green, Michael S Kaminer, Holly Casey Wall, Mark R Magnusson
Förderung
- Revelle Aesthetics, Inc
Zitieren
APA
Stevens, W. G., Green, J. B., Layt, C., Kaminer, M. S., Harrington, J., Fan, L., Wall, H. C., Fabi, S., & Magnusson, M. R. (2023). Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjac291
Vancouver
Stevens WG, Green JB, Layt C, Kaminer MS, Harrington J, Fan L, et al. Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months. Aesthetic Surgery Journal. 2023. doi:10.1093/asj/sjac291
BibTeX
@article{Stevens2023,
author = {Stevens, W Grant and Green, Jeremy B and Layt, Craig and Kaminer, Michael S and Harrington, Jennifer and Fan, Larry and Wall, Holly Casey and Fabi, Sabrina and Magnusson, Mark R},
title = {Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months},
journal = {Aesthetic Surgery Journal},
year = {2023},
doi = {10.1093/asj/sjac291}
}
EUVIMED